共 143 条
[1]
Cristescu R(2015)Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes Nat Med 21 449-456
[2]
Lee J(2012)Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Lancet 379 315-321
[3]
Nebozhyn M(2006)Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11-20
[4]
Bang YJ(1988)Chemotherapy of advanced gastric cancer: present status, future prospects Semin Oncol 15 42-49
[5]
Kim YW(2011)MiRNA signature associated with outcome of gastric cancer patients following chemotherapy BMC Med Genomics 4 79-11355
[6]
Kim YW(2014)MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin World J Gastroenterol 20 11347-1007
[7]
Yang HK(2009)Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy Cancer Chemother Pharmacol 64 1001-24
[8]
Cunningham D(2010)DNA polymerase eta protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy J Transl Med 8 126-139
[9]
Allum WH(2006)Increased ERCC expression correlates with improved outcome of patients treated with cisplatin as an adjuvant therapy for curatively resected gastric cancer Cancer Res Treat 38 19-243
[10]
Stenning SP(2011)Biological functions of microRNAs: a review J Physiol Biochem 67 129-477